Progesterone receptor was purified in a single step from human uteri using immunoaffinity chromatography with monoclonal antibodies raised against the rabbit receptor. A total of 39 monoclonal antibodies were prepared against the human receptor and characterized. Immunoblot experiments using crude uterine cytosol or purified receptor showed that the antibodies belonged to three groups: they recognized either a single receptor species (apparent molecular mass 110 kDa), two species (110 and 79 kDa) or three species (1 10, 79 and 65 kDa). The species specificity of the antibodies was very variable; some recognized only the human receptor, others interacted with several mammalian receptors (rabbit, guinea pig and rat), while a single one also cross-reacted with the chick receptor. The epitopes recognized by 15 of the antibodies showing the strongest affinity for the human receptor were mapped using a method recently described [Lorenzo, Jolivet & Milgrom (1988) 
INTRODUCTION
Initial purification of rabbit progesterone receptor allowed first the preparation of polyclonal [1] and then monoclonal [2] antibodies. These antibodies crossreacted with varying affinities with receptors from most mammalian species and especially from humans. Some have thus been used for immunocytochemical [3] and immunochemical [4] studies of human receptors in various tissues. More recently, some monoclonal antibodies have been prepared against chicken [5] , and human [6] [7] [8] progesterone receptors. However, it appeared interesting to prepare a large panel of monoclonals against the human receptor in order to define and study its immunogenic domains. This analysis has been made possible by the cloning and sequencing of the human progesterone receptor gene [9] and by the description of a simple method of epitope mapping [10] . Moreover, it is known that each monoclonal antibody displays different properties in terms of affinity for the antigen when the latter is soluble, or fixed in histological preparations or on membranes for immunoblotting. The availability of a large number of monoclonals thus allows the antibody having the optimal characteristics for each specific use to be selected.
EXPERIMENTAL Immunoaffinity purification of progesterone receptor
Fragments of human uteri were obtained from hysterectomies. They were pooled and kept in liquid N2 until use. The tissue was homogenized with a Waring Blender (Bioblock, Illkirch, France) in 10 mM-Tris/ 50 mM-NaCl buffer, pH 8 (2.5 g/ml of buffer). The buffer contained the following proteolysis inhibitors: pepstatin (1 jtg/ml, Sigma), phenylmethanesulphonyl fluoride (1 mM, Sigma), leupeptin (0.1 mm, Sigma), bacitracin (0.1 mg/ml, Sigma) and aprotinin (36.5 ,ug/ml, Biosys., Compiegne, France). Cytosol obtained by centrifugation for 90 min at 0°C and 105 000 g was incubated for 2 h at 0°C with 20 nM-[3H]ORG.2058 (16a-ethyl-21-hydroxy-1 9-nor[6,7-3H]pregn-4-ene-3,20-dione) [ Purified monoclonal antibody Mo482, raised against rabbit receptor but cross-reacting with human receptor, was linked to Affigel-10 (15 mg of antibody/ml of gel) as described in the Bio-Rad (Richmond, CA, U.S.A.) instruction bulletin.
During the immunopurification procedure, uterine cytosol (500-700 ml, flow 24-30 ml/h) was successively Vol. 260 passed on three columns to decrease non-specific binding to the immunomatrix (20 ml of Protein A-Sepharose CL-4B; 30 ml of Affigel-10; 15 ml of Affigel-10-IDA10, a non-receptor-related antibody [ 1] ). The steroid-receptor complexes were retained on Affigel-10-Mo482 immunomatrix (4 columns of 1 ml each). After extensive washing performed as previously described [12] , the receptor-steroid complexes were eluted in 50 mMammonium carbonate buffer, pH 10.8 [12] . Assay of steroid-receptor complexes This was performed with dextran-coated charcoal [13] or by the hydroxyapatite method [14] . The latter was only used when protein concentration was < 1 mg/ml.
Protein concentration
This was measured by the Amido Schwartz method [15] . The DNA of the resulting vector was either used intact or after restriction with XbaI (site in polylinker following the insert), HincII (site at nucleotide 1367), MluI (site at nucleotide 1115), BalI (site at nucleotide 887), ApaI (site at nucleotide 624) and Sacl (site at nucleotide 363). Transcription in vitro was performed according to the instruction bulletin of Promega Biotec. Translation of the resulting mRNA was done in a reticulocyte lysate system in presence of L-[4,5-3H]leucine (specific activity 177 Ci/mmol; Amersham International). The proteins obtained by cell-free translation were immunoprecipitated with anti-receptor monoclonal antibodies, electrophoresed and submitted to autoradiography in the presence of EN3HANCE (New England Nuclear).
RESULTS

Immunopurification of the human uterine progesterone receptor
An immunomatrix was prepared using antibody Mo482. This monoclonal antibody has been raised against the rabbit progesterone receptor but has been shown to have a high affinity for the human receptor [12] (A. Jolivet, unpublished work). Uterine cytosol incubated with the tritiated progestin ORG.2058 was chromatographed through the column and receptorsteroid complexes were eluted at alkaline pH.
The specific activity of the starting material (steroidreceptor complexes in uterine cytosol) varied between 0.3 and 0.6 pmol of receptor/mg of protein in the various experiments. After elution the specific activity was about 1800-3000 pmol of receptor/mg of protein and the receptor yield was 20-25 00. Polyacrylamide-gel electrophoresis in the presence of SDS showed two major bands of molecular mass of about 110 and 79 kDa, and a minor band at 65 kDa (Fig. 1) . Immunoblotting with a polyclonal antibody prepared against highly-purified rabbit 110 kDa receptor [4] showed that all three bands reacted with the antibody and were thus probably different species of the human receptor molecule. This was later confirmed with monoclonals raised against the human receptor (see Fig. 4 ). The relative proportions of the bands varied in different experiments. Preparation and characterization of monoclonal antibodies against the human uterine progesterone receptor Purified receptor preparations were used to immunize mice. Hybridomas were prepared and screened as de- Mapping of the epitopes recognized by antireceptor antibodies Fourteen of the antibodies raised against the human receptor, and two antibodies raised against the rabbit receptor which cross-reacted with human, were studied using a method previously analysed in detail [10] . Briefly, this method, which allows the study of continuous (by opposition to conformational) epitopes involves insertion of the cDNA coding for the receptor in a vector containing signals necessary for acellular transcription and translation. This allows synthesis, totally in vitro, of radioactive receptor and study of its immunoprecipitation. The cDNA inserted in the vector is then cut at various sites with restriction enzymes. After transcription and translation in vitro this yields receptor truncated to various extents in its C-terminal region. The truncated receptor is immunoprecipitated until the sequence encoding the epitope recognized by the monoclonal antibody has been deleted from the gene. For instance, in Fig. 4(b [10] . (Fig. 5) shows that the latter group of monoclonals corresponds to the Nterminal part of the protein (amino acids interact with epitopes localized downstream (towards the C-terminus) from amino acid 296 label the three receptor species. Thus the N-terminal limit of the 65 kDa species must lie between amino acids 208 and 296.
DISCUSSION
We have previously devised a method for immunoaffinity purification of rabbit progesterone receptor [12] . The receptor could be recovered in its native state by using elution with high-pH buffer, conditions in which the receptor is not inactivated. This method was later applied by Estes et al. [6] to the purification of human receptor from T47D cells using an antibody raised by Sullivan et al. [5] against chick receptor. The antibody interacted only with the 110 kDa form of receptor and thus only this form was purified.
In the present study we have used an antibody which recognizes all three species of receptor and therefore allows purification with relatively high yields of large amounts of receptor from uteri obtained from hysterectomies. Hundreds of micrograms of receptor may easily be purified from this source allowing structural studies and analysis of interactions between receptor and hormone-responsive elements of genes (A. Bailly, unpublished work).
A total of 39 monoclonal antibodies was obtained (in addition to the antibodies against the rabbit receptor which strongly cross-reacted with the human receptor). They were of a variety of subclasses and exhibited varying affinities towards the receptor. Their epitopes were mapped and found to correspond to several sites, all of which were localized in the N-terminal half of the receptor molecule. Prediction of antigenicity suggests the existence of such sites mainly in this region although, theoretically, some of these sites should have been present in the Cterminal half. The lack of experimental antigenicity of this part of the molecule as observed in the present study may be consistent with its extremely high conservation between species. A similar observation has been made for the rabbit progesterone receptor [10] . The monoclonal antibodies raised against the rat glucocorticoid receptor were also found to interact with the protein in a region located outside the hormone-and DNA-binding domains [18] . It cannot however be excluded that the lack of immunogenicity of these regions of receptor is due to other mechanisms, e.g. differences in catabolism in mice ofthe various parts ofthe injected protein, or a genetically restricted immunological response of this specific strain of mice. The method of epitope localization which was used in these experiments is only applicable to epitopes consisting of linear and relatively short stretches of amino acids and cannot allow the study of conformational epitopes including amino acids located at a large distance in the primary structure of the protein. [12, 19] . In the case of the human receptor this point is still debated [6] . The cDNA for the human progesterone receptor has been cloned [9] . To analyse the function of the protein, mutagenesis experiments in vitro are now being undertaken. The availability of monoclonal antibodies recognizing well defined immunogenic domains will be of great value in such studies.
